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Research Article    
Abstract 
The Intrauterine Device (IUD) is a well-accepted method of contraception. Most women are 
currently using it because of its effectiveness, longevity, and affordability. Moreover, users need 
no strict routine instructions for IUD. However, many women in the absence of any pre-existing 
conditions that may impair sexual functions discontinue the method due to poor sexual 
satisfaction. This paper aims to assess and measure the effects of IUDs on sexual function in 
women with no underlying condition over a period of 12 months. This study employed a 
longitudinal approach. To be eligible to participate, the study enrolled 260 women who have 
chosen to use IUDs willingly on their own at these selected centers during this period and are 
aged 20 years and above. It collected data at baseline and at 12 months of use. 
Measurements at these two timelines were done using the Female Sexual Function Index (FSFI). 
The prevalence of female sexual dysfunction among participants after 12 months was 47.7% 
(124). In the analysis of Mean scores, FSFI at baseline and at 12 months was 31.31 and 24.76 
respectively (p<0.05). Significantly reduced scores (p=0.001), for all the six domains (desire, 
arousal, lubrication, orgasm, satisfaction, and pain) of sexual function were noted. Desire and 
pain were the most affected areas of sexual function with very low scores. Without any 
underlying and related triggers of sexual health, the study discovered that IUDs have the 
potentials to cause female sexual dysfunction in almost half of its users. 
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1. Introduction 
Sexual functions are needed throughout the stages of life. It is needed for sexual orientation, 
gender identity, sexual pleasure, intimacy, eroticism, and reproduction. Good sexual 
functioning involves the ability to start sexual stimulation, experience lubrication, orgasm, and 
enjoy sexual pleasure in the absence of pain and discomfort. Human sexuality also includes 
social functioning, culture, sexual identity, and spirituality. Sexual functioning is different in both 
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men and women by the nature of their reproductive organs(Gorzalka et al., 2010). These 
reproductive organs enable men and women to enjoy sexual pleasure and reproduce their 
young ones. According to the World Health Organization, sexual health must include the 
physical, emotional, and social health of women. For a woman to have good health, there 
must be good sexual functioning(Kariman et al., 2017). In the event of sexual life, women face 
many challenges particularly about the type of contraceptive to choose (Panchalee et al., 
2014). Almost all contraceptive methods have probable effects on a sexual relationship and 
functioning(Toorzani et al., 2010). 
The IUD is a long-acting reversible contraceptive method that is highly effective at preventing 
pregnancy, convenient to use, requires no strict instructions, and is well accepted(Ferreira et al., 
2019). It is one of the most popular options because it offers protection for a long period, there is 
a quick return to fertility after discontinuation, and cost of uptake is affordable(Okunlola et al., 
2009). They are effective for preventing pregnancy, highly acceptable and many women are 
using them(Peipert et al., 2011). Globally,14.3% of women are currently using it but the 
distribution of users in developing and developed countries differs(Buhling et al., 2014).In 
developing countries, 14.5% of reproductive-aged women are using it whereas in the 
developed world the percentage is only 7.6%(d’Arcangues, 2007). Statistics from the Ghana 
Health Service and other credible sources such as the Planned Parenthood Association of 
Ghana indicate there has been a 40% decline in the patronage of the device since the year 
2000 and currently only 2% or less of reproductive-aged women in Ghana are using 
them(GDHS,2014). Researchers have stated that sexual function determines a woman's 
contraceptive preference, practices, and period of use(Higgins & Smith, 2016).IUDs may affect 
sexual functions which are factors influencing their acceptability in general(Higgins & Smith, 
2016). Some women refuse to use the device due to concerns and effects on sexual life. 
According to some women, having a device with strings attached inside their bodies seems 
strange and foreign (Peipert et al., 2011). A Study done by Fleming KL et al. found that women 
with such complaints believe that the device might hurt them. Satisfactory sexual habit or good 
sexual functioning is one of the parameters of quality life but women on IUDs may have female 
sexual dysfunction. IUDs still have many advantages and women using them can enjoy full 
sexual life. On the other hand, the device can interrupt sexual life and satisfaction. Intrauterine 
contraception can cause pain during insertion, infections, abdominal cramps, and unexplained 
bleeding episodes. After IUD insertion, some women develop persistent or recurrent sexual 
problems leading to a lifelong challenge(Gonçalves et al., 2016). In the absence of any 
underlying intervention and condition, the prevalence of Female Sexual Dysfunction among 
women ranges from 27 to 70% (de Castro Coelho & Barros, 2019). Therefore, the usage of 
certain birth controls like the IUD can cause more sexual health and psychological problems for 
women. The drivers of sexual dysfunction when a woman is using contraceptives is not only 
related to the method of contraception. Other conditions or factors like diabetes, smoking, 
sexual abuse medications, alcoholism, depression, menopause, etc. could impair the quality of 
sexual life. In the absence of these conditions, the impact of IUDs on sexual health has not been 
assessed well in Ghana among reproductive-aged women. The current study employed the 
Female Sexual Function Index to measure sexual functions in women screened with no pre-
existing conditions and have accepted to use Intrauterine Contraception over an observation 
period of 12 months. 
 
2. Materials and Methods 
This study employed a longitudinal approach to investigate the sexual function of women using 
IUDs. The study was conducted in six selected family planning centers in urban Accra and all 
respondents were recruited between January and December 2019. To be eligible to 
participate, the study enrolled women who have chosen to use IUDs willingly on their own at 
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these selected centers during this period and are aged 20 years and above. The minimum age 
of 20 was chosen to ensure the maturity of sexual functions(Hayes et al., 2008). This study was 
reviewed and approved by the Research Ethics Committees of the University College Hospital 
Ibadan (NHREC/05/01/2008a) and Ghana Health Service (GHS-ERC 009/02/19). Participation 
was voluntary and the purpose of the study was fully explained to the respondents. Their 
informed consent was also obtained. Participants were screened as follows after meeting the 
above mentioned preliminary criteria. Women with FSFSI scores less than or equal to 26.55 were 
excluded from the study because it signifies sexual dysfunction. Also, participants were 
excluded if they have a history of depression, sexual abuse, low self-esteem, neurological 
diseases, pelvic floor surgeries, infections, a cardiovascular disease affecting blood vessels 
(Hypertension), diabetes, smoking, alcoholism, menopause and any condition that can affect 
sexual life. Data was collected using a questionnaire form and the female sexual function index 
(FSFI) as the baseline. The questionnaire form includes socio-economic characteristics and 
obstetric history. A total number of 260 respondents met the preliminary criteria and the initial 
baseline screening. They were observed, monitored with caution not modify their behavior or 
cause interference within a period of 12months or up to December 2019. Then they were made 
to complete the FSFI again. They were instructed to fill the questionnaire based on or reflecting 
their sexual experiences during the 12 months of IUD use. Statistical analysis was performed 
using the Statistical Package for the Social Science (SPSS) version 20. The assumption of a 
normal distribution was tested by the Shapiro Wilk test, the p-value was less than 0.05 and the 
test showed that data was not normally distributed. Hence the non-parametric data were 
analyzed using the Wilcoxon test. Descriptive statistics for continuous variables were expressed 
as mean and standard deviation while categorical variables and prevalence of female sexual 
dysfunction were expressed as numbers with percentages. Scores of FSFI between the two 
timelines were compared and the level of significance was set as p<0.05.  
 
3. Results 
A total of 260 women were recruited and followed up successfully at the end of the observation 
period. The demographic characteristics of the participants are shown in Table 1.  
Table 1: Socio-demographic characteristics of Participants 










In union but not married 
Educational level 














Menstrual Patterns                       
Regular                                                                                                                               
Irregular 
Satisfied with Current Relationship 
No 
Yes                
 
26 (10 %) 
104 (40%) 
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The majority of the participants were women within the age of 26-30 years (40%), followed by 
31-35 years (30 %) and the least been 41-45(5%). Married women were 65%, 33.3% had 
secondary education with 28.3% been educated to the tertiary level. Most of the women were 
parous (80%) while the remaining have not given birth before, 53.4% were employed at the time 
of the study,73.3% had a regular menstrual pattern and 90.0% indicated that they were satisfied 
with their current relationship. 
The FSFI and domain scores at the beginning of the study were as follows: FSFI (31.31±2.67), 
desire (4.84±0.87), arousal (5.41±0.48), lubrication (5.33±0.59), orgasm (5.27±0.68), Satisfaction 
(5.47±0.52) and Pain (4.95±0.87). At 12 months, FSFI and domain scores obtained were as 
follows: FSFI scores (24.76±7.88), desire (3.93±1.21), arousal (4.18±1.32), lubrication (4.14±1.39), 
orgasm (4.26±1.46), satisfaction (4.13±1.44) and Pain (4.07±1.43).  
 
Table 2: Scores of Female Sexual Function Index Components at Baseline and 12 months 
FSFI Domain Score 
 
Baseline At 12 months P-value 
    
Desire 4.84 ± 0.87 3.93 ±1.21 0.001 
Arousal 5.42 ± 0.48 4.18±1.32 0.001 
Lubrication 5.42 ± 0.48 4.14± 1.39 0.001 
Orgasm 5.27 ±  0.68 4.26± 1.46 0.001 
Satisfaction 5.47 ±  0.52 4.13± 1.44 0.001 
Pain 4.95 ± 0.87 4.07± 1.43 0.001 
Total FSFI Scores 31.31 ± 2.67 24.76 ±7.88 0.001 
p<0.05(Wilcoxon Test) 
 





Fig. 1: Bar chart diagram of FSFI Scores at two timelines  
 
The prevalence of Female Sexual dysfunction among the participant was 47.7% (Table 4). 









Desire Arousal Lubrication Orgasm Satisfaction Pain Total Score
Baseline At 12 months
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among women using IUDs representing (4.26 ±1.46) 17.2% and (4.18± 1.32)16.8% respectively. 
Sexual Desire and Pain were the least been (3.93 ±1.21) 15.8% and (4.07± 1.43) 16.4%. 
 
Table 3: Prevalence of Sexual Dysfunction at 12 months 
FSFI Scores of IUD Users at 12 months n     % FSFI Scores Mean + SD 
 < 26.55 (Sexual Dysfunction) 124 47.7 17.39 ± 4.53 
 ≥  26.55( Normal Sexual Function) 136 52.3 31.47 ± 3.35 
Total 260 100.0 24.76 ± 7.88 
 
4. Discussion   
Impairment of sexual functions can be affected by many factors including psychological, 
physiological, cultural, and others. One of the considerable factors among couples is the 
decision to choose a contraceptive method. The choice of a family planning method has 
effects on sexual functions. Researchers have stated that the prevalence of sexual dysfunction 
in women is likely to be around 40%(Laumann et al., 1999). This study investigated this concept 
in IUD Users over a period of 12 months and found that without any underlying causes, the 
prevalence of female sexual dysfunction was 47.7%. These results were a little similar to that of 
Panchalee et al., 2014 who found a 50.9% prevalence of FSD in IUD users. However, their study 
collected data from women in a society with different races and lifestyles without screening. 
The method they used was a cross-sectional but not longitudinal or observational study and the 
time duration was short.  
The overall mean scores of FSFI at baseline were 31.31±2.67 while the corresponding scores at 12 
months were 24.76±7.88, which indicated a significant reduction. The study also considered the 
effects of IUDs on the various domains of sexual function. Low scores were obtained in the 
desire and pain domain than in other areas. Low scores signify worse functioning in these 
domains. IUD Users might have decreased sexual function, especially in the desire and pain 
domain compared with women with no IUDs. It is also possible that the causes of desire and 
pain disorders are highly related. With our findings, there was a statistically significant difference 
between overall FSFI and domain Scores between the two timelines (p<0.05).  
 
5. Conclusion 
It is important that researchers identify contraceptives that affect sexual behaviors and 
functions, consider their outcomes, and decide whether it meets the client's sexual needs. To 
increase the desire of women to use IUDs, more attention must be directed to investigating this 
phenomenon. The effects of long-term contraceptives such as the IUD on sexual functioning 
must be well understood. IUDs have numerous advantages, long-term use with good 
compliance, and fewer instructions to adhere to. The IUDs have the potentials to cause sexual 
dysfunction after a long period of use such as 12 months. Therefore, women who prefer this 
method because of the benefits should be informed and educated on sexual dysfunction 
associated with the use of the device. In the event that a woman chose to use this method, the 
user should be closely monitored, followed up, counseled, and managed where possible. 
 
6. Limitations of the study 
Although the sample size is adequate, a large number of women using IUDs included in the 
study would have given more information about sexual function and dysfunction. However, the 
number of women patronizing the device is declining, and therefore sample size is considered 
limited. 
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